Developments in new progestagens for oral contraception.
Eyong
E
E
D001695:Biology; D002319:Cardiovascular System; D055598:Chemical Phenomena; D002621:Chemistry; D002784:Cholesterol; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003339:Corpus Luteum Hormones; D004194:Disease; D004467:Economics; D004703:Endocrine System; D005193:Family Planning Services; D006728:Hormones; D008055:Lipids; D008660:Metabolism; D009930:Organic Chemicals; D010827:Physiology; D011374:Progesterone; D045167:Progesterone Congeners; D011372:Progestins; D012102:Reproductive Control Agents; D012106:Research; D013672:Technology
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003339:Corpus Luteum Hormones; D006728:Hormones; D008055:Lipids; D009930:Organic Chemicals; D045167:Progesterone Congeners; D011372:Progestins; D012102:Reproductive Control Agents; D011374:Progesterone; D002784:Cholesterol
Biology; Cardiovascular Effects--prevention and control; Cholesterol; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Corpus Luteum Hormones; Diseases; Economic Factors; Endocrine System; Family Planning; Hormones; Ingredients And Chemicals; Lipid Metabolic Effects; Lipids; Metabolic Effects; Oral Contraceptives; Oral Contraceptives, Low-dose; Organic Chemicals; Physiology; Progestational Hormones; Progesterone; Progestins, Low-dose; Reproductive Control Agents; Research And Development; Technology